{{drugbox
| drug_name         = 3',4'-Methylenedioxy-α-pyrrolidinobutyrophenone
| IUPAC_name        = 1-(2''H''-1,3-Benzodioxol-5-yl)-2-(pyrrolidin-1-yl)butan-1-one
| image             = 3',4'-Methylenedioxy-α-pyrrolidinobutiophenone.svg
| CAS_number        = 784985-33-7
| ATC_prefix        =
| ATC_suffix        =
| PubChem           = 71300672
| DrugBank          =
| ChemSpiderID = 52084589
| C=15|H=19|N=1|O=3
| molecular_weight  = 261.316 g/mol
| smiles            = CCC(C(=O)C1=CC2=C(C=C1)OCO2)N3CCCC3
| StdInChI = 1S/C15H19NO3/c1-2-12(16-7-3-4-8-16)15(17)11-5-6-13-14(9-11)19-10-18-13/h5-6,9,12H,2-4,7-8,10H2,1H3
| StdInChIKey = OLVLMDVPMCIBQW-UHFFFAOYSA-N
| bioavailability   =
| protein_bound     =
| metabolism        =
| elimination_half-life =
| excretion         =
| pregnancy_AU      =  <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US      =  <!-- A / B            / C / D / X -->
| pregnancy_category=
| legal_AU          =  <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA          =  Schedule I
| legal_UK          =  Class B
| legal_US          =  <!-- OTC                   / Rx-only  / Schedule I, II, III, IV, V -->
| legal_status      = Illegal in China and Poland
| routes_of_administration =
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 979L917V7T
}}

'''3',4'-Methylenedioxy-α-pyrrolidinobutyrophenone''' ('''MDPBP''') is a [[stimulant]] of the [[substituted cathinone|cathinone]] class developed in the 1960s,<ref>{{citation|first1=Koeppe|last1=Herbert|first2=Zeile|last2=Karl|first3=Ludwig|last3=Gerhard|title=Patent DE1545591 - Verfahren zur Herstellung von α-Aminoketonen mit heterocyclischer Aminogruppe|url=https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19690807&DB=&locale=en_EP&CC=DE&NR=1545591A1&KC=A1|date=28 May 1965|language=de}}</ref><ref>{{cite journal|first1=Renata|last1=Kolanos|first2=Ernesto|last2=Solis|first3=Farhana|last3=Sakloth|first4=Louis J. De|last4=Felice|title="Deconstruction" of the Abused Synthetic Cathinone Methylenedioxypyrovalerone (MDPV) and an Examination of Effects at the Human Dopamine Transporter|journal=ACS Chemical Neuroscience|date=18 December 2013|pages=1524–1529|volume=4|issue=12|pmid=24116392|pmc=3867964|doi=10.1021/cn4001236|first5=Richard A.|last5=Glennon}}</ref> which has been reported as a novel [[designer drug]].<ref>{{cite journal|first1=Folker|last1=Westphal|first2=Thomas|last2=Junge|first3=B.|last3=Klein|first4=Giselher|last4=Fritschi|title=Spectroscopic characterization of 3,4-methylenedioxypyrrolidinobutyrophenone: A new designer drug with α-pyrrolidinophenone structure|url=http://www.sciencedirect.com/science/article/pii/S0379073811000296|journal=Forensic Science International|date=15 June 2011|pages=126–132|volume=209|issue=1–3|doi=10.1016/j.forsciint.2011.01.016|pmid=21316166|first5=Ulrich|last5=Girreser}}</ref><ref>{{cite journal|first1=Marek|last1=Wiergowski|first2=MateuszK.|last2=Woźniak|first3=Marzena|last3=Kata|first4=Marek|last4=Biziuk|title=Determination of MDPBP in postmortem blood samples by gas chromatography coupled with mass spectrometry|journal=Monatshefte für Chemie - Chemical Monthly|date=August 2016|issn=0026-9247|pages=1415–1421|volume=147|issue=8|pmid=27546909|pmc=4971041|doi=10.1007/s00706-016-1780-0}}</ref> MDPBP is sometimes sold under the name "NRG-1" as a mixture with other cathinone derivatives, including [[flephedrone]], [[pentylone]], [[4'-Methyl-α-pyrrolidinopropiophenone|MαPPP]] and its higher homologue [[Methylenedioxypyrovalerone|MDPV]].<ref>{{cite journal|first1=Simon D.|last1=Brandt|first2=Sally|last2=Freeman|first3=Harry R.|last3=Sumnall|first4=Fiona|last4=Measham|title=Analysis of NRG ‘legal highs’ in the UK: identification and formation of novel cathinones|url=http://onlinelibrary.wiley.com/doi/10.1002/dta.204/abstract|journal=Drug Testing and Analysis|date=September 2011|issn=1942-7611|pages=569–575|volume=3|issue=9|doi=10.1002/dta.204|pmid=21960541|first5=Jon|last5=Cole}}</ref> As with other [[substituted cathinones|cathinones]], MDPBP has been shown to have reinforcing effects in rats.<ref>{{cite journal|last1=Gannon|first1=BM|last2=Galindo|first2=KI|last3=Mesmin|first3=MP|last4=Sulima|first4=A|last5=Rice|first5=KC|last6=Collins|first6=GT|title=Relative reinforcing effects of second-generation synthetic cathinones: Acquisition of self-administration and fixed ratio dose-response curves in rats.|journal=Neuropharmacology|date=12 August 2017|doi=10.1016/j.neuropharm.2017.08.018|pmid=28811192}}</ref>

The main metabolic steps are thought to be demethylenation followed by methylation of one hydroxy group, aromatic and side chain hydroxylation, oxidation of the pyrrolidine ring to the corresponding lactam as well as ring opening to the corresponding carboxylic acid. CYP2C19 and CYP2D6 have been identified as the isoenzymes mainly responsible for demethylenation.<ref>{{cite journal|first1=Markus R.|last1=Meyer|first2=Sandra|last2=Mauer|first3=Golo M. J.|last3=Meyer|first4=Julia|last4=Dinger|title=The ''in vivo'' and ''in vitro'' metabolism and the detectability in urine of 3’,4’-methylenedioxy-alpha-pyrrolidinobutyrophenone (MDPBP), a new pyrrolidinophenone-type designer drug, studied by GC-MS and LC-MS<sup>n</sup>|url=http://onlinelibrary.wiley.com/doi/10.1002/dta.1559/abstract|journal=Drug Testing and Analysis|date=July–August 2014|issn=1942-7611|pages=746–756|volume=6|issue=7-8|doi=10.1002/dta.1559|pmid=24124065|first5=Birgit|last5=Klein|first6=Folker|last6=Westphal|first7=Hans H.|last7=Maurer}}</ref>

==Legal Status==

As of October 2015 MDPBP is a controlled substance in Poland and China.<ref>{{cite web | url=http://www.sfda.gov.cn/WS01/CL0056/130753.html | title=关于印发《非药用类麻醉药品和精神药品列管办法》的通知 | publisher=China Food and Drug Administration | date=27 September 2015 | language=zh | accessdate=1 October 2015}}</ref>

==See also==
* [[Alpha-Pyrrolidinobutiophenone|α-Pyrrolidinobutiophenone]] (α-PBP)
* [[Butylone]]
* [[3',4'-Methylenedioxy-α-pyrrolidinopropiophenone]] (MDPPP)
* [[Methylenedioxypyrovalerone]] (MDPV)

==References==
{{Reflist}}

{{Stimulants}}
{{Adrenergics}}
{{Dopaminergics}}
{{MDxx}}

{{DEFAULTSORT:Methylenedioxy-alpha-pyrrolidinobutyrophenone, 3',4'-}}
[[Category:Designer drugs]]
[[Category:Pyrrolidinophenones]]
[[Category:Benzodioxoles]]


{{nervous-system-drug-stub}}